In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This pilot early phase I trial studies how well ferumoxytol-enhanced magnetic resonance
imaging (MRI) correlates with inflammatory (macrophage) responses in pediatric patients with
malignant brain tumors. If there is good correlation, ferumoxytol-enhanced MRI can serve as a
noninvasive imaging biomarker of inflammation.